InvestorsHub Logo
Followers 17
Posts 1755
Boards Moderated 0
Alias Born 11/13/2013

Re: johnking29 post# 295587

Thursday, 09/03/2020 11:17:16 AM

Thursday, September 03, 2020 11:17:16 AM

Post# of 423432
From PR:

"Amarin anticipates that generics companies, when they launch in the United States, are likely to have limited supply capacity for VASCEPA. Based on this assumption and given the need for greater awareness of VASCEPA by healthcare professionals and at-risk patients, Amarin intends to continue current promotion levels of VASCEPA in the United States. After assessing the scope, timing and pricing of potential generic competition, Amarin will decide whether to further expand, contract or maintain such levels of VASCEPA promotion."

Big mistake. Shit can the DTC and shit can the sales force. JT is gonna bleed this company dry. Watch and see. Also, gear up for another dilution (big one at these prices)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News